Table 1 summarizes the distinctive clinical features of BGS and RBS individuals whose clinical phenotype could be confirmed by molecular analysis of the respective RECQL4 and ESCO2 genes. This evidence concerns the gene ESCO2 and Baller-Gerold syndrome.